A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 74.50
+0.50 (0.68%)
Aug 26, 2026, 1:30 PM CST
A Plus Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 475.56 | 604.35 | 360.97 | 319.07 | 237.69 | 305.09 |
Short-Term Investments | 6 | 4 | 30 | - | 1 | 1 |
Cash & Short-Term Investments | 481.56 | 608.35 | 390.97 | 319.07 | 238.69 | 306.09 |
Cash Growth | -27.68% | 55.60% | 22.54% | 33.67% | -22.02% | 5.44% |
Accounts Receivable | 180.04 | 178.33 | 184.53 | 141.67 | 146.64 | 133.31 |
Other Receivables | 0.05 | 0.18 | - | 2.11 | 3.07 | 3.07 |
Receivables | 180.09 | 178.5 | 184.53 | 143.77 | 149.71 | 136.38 |
Inventory | 367 | 354.54 | 286.94 | 283.76 | 295.69 | 300.67 |
Prepaid Expenses | 36.89 | 39.37 | 29.26 | 17.49 | 24.08 | 16.06 |
Other Current Assets | 2.29 | 6.3 | 5.15 | 5.49 | 0.61 | 2.07 |
Total Current Assets | 1,068 | 1,187 | 896.85 | 769.58 | 708.78 | 761.27 |
Property, Plant & Equipment | 362.99 | 243.75 | 251.91 | 259.02 | 259.63 | 233.38 |
Long-Term Investments | 82.2 | 87.66 | - | - | - | - |
Other Intangible Assets | 4 | 3.97 | 6.51 | 8.24 | 176.2 | 178.16 |
Long-Term Deferred Tax Assets | 16.92 | 13.99 | 12.66 | 31.24 | 12.7 | 9.8 |
Other Long-Term Assets | 14.47 | 13.58 | 9.38 | 3.26 | 17.2 | 23.24 |
Total Assets | 1,548 | 1,550 | 1,177 | 1,071 | 1,175 | 1,206 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 40.54 | 41.06 | 39.4 | 28.9 | 42.23 | 39.81 |
Accrued Expenses | - | 70.11 | 72.48 | 43.69 | - | - |
Short-Term Debt | - | - | - | - | - | 37.8 |
Current Portion of Long-Term Debt | - | 4.82 | 4.72 | 4.78 | - | - |
Current Portion of Leases | 3.98 | 8.27 | 8.07 | 8.64 | 8.96 | 9.78 |
Current Income Taxes Payable | 26.01 | 32.93 | 2.95 | 19.56 | 20.38 | 7.97 |
Current Unearned Revenue | 4.36 | 2.96 | 0.91 | 1.49 | 6.83 | 0.9 |
Other Current Liabilities | 108.28 | 37.98 | 34.77 | 35.77 | 95.23 | 107.08 |
Total Current Liabilities | 183.17 | 198.13 | 163.31 | 142.83 | 173.63 | 203.35 |
Long-Term Debt | 155.71 | 82.38 | 87.2 | 93.83 | 116.44 | 153.98 |
Long-Term Leases | 0.59 | 0.62 | 6.82 | 5.79 | 5.67 | 3.31 |
Long-Term Deferred Tax Liabilities | 5.85 | 2.99 | 0.01 | - | 0.05 | 0.11 |
Other Long-Term Liabilities | 0.26 | 0.32 | 0.94 | 0.93 | 0.92 | 1.16 |
Total Liabilities | 345.58 | 284.45 | 258.27 | 243.38 | 296.71 | 361.91 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 345.71 | 345.71 | 304.71 | 304.71 | 304.71 | 304.71 |
Additional Paid-In Capital | 549.43 | - | - | 360.01 | 358.55 | 358.55 |
Retained Earnings | 331.65 | 347.55 | 300.05 | 177.04 | 209.47 | 179 |
Treasury Stock | -43.94 | -38.66 | - | -14.15 | - | - |
Comprehensive Income & Other | 16.92 | 608.19 | 314.29 | 0.35 | 5.08 | 1.68 |
Total Common Equity | 1,200 | 1,263 | 919.05 | 827.94 | 877.81 | 843.94 |
Minority Interest | 3.05 | 2.77 | - | - | - | - |
Shareholders' Equity | 1,203 | 1,266 | 919.05 | 827.94 | 877.81 | 843.94 |
Total Liabilities & Equity | 1,548 | 1,550 | 1,177 | 1,071 | 1,175 | 1,206 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 160.27 | 96.1 | 106.81 | 113.03 | 131.07 | 204.87 |
Net Cash (Debt) | 321.29 | 512.26 | 284.16 | 206.03 | 107.62 | 101.22 |
Net Cash Growth | -43.09% | 80.27% | 37.92% | 91.45% | 6.32% | -59.77% |
Net Cash Per Share | 9.33 | 15.57 | 9.36 | 6.81 | 3.53 | 3.50 |
Filing Date Shares Outstanding | 34.08 | 33.7 | 30.47 | 30.18 | 30.22 | 28.58 |
Total Common Shares Outstanding | 34.08 | 33.7 | 30.47 | 30.18 | 30.22 | 28.58 |
Working Capital | 884.65 | 988.93 | 733.54 | 626.75 | 535.15 | 557.92 |
Book Value Per Share | 35.20 | 37.48 | 30.16 | 27.43 | 29.04 | 29.53 |
Tangible Book Value | 1,196 | 1,259 | 912.54 | 819.7 | 701.6 | 665.77 |
Tangible Book Value Per Share | 35.08 | 37.36 | 29.95 | 27.16 | 23.21 | 23.29 |
Land | - | 117.34 | 117.34 | 117.34 | - | - |
Buildings | - | 116.27 | 115.92 | 103.55 | - | - |
Machinery | - | 34.77 | 35.15 | 46.84 | - | - |
Construction In Progress | - | 0.1 | 0.21 | 13.48 | - | - |
Leasehold Improvements | - | 12.79 | 5.19 | 5.62 | - | - |